JP2001504479A5 - - Google Patents

Download PDF

Info

Publication number
JP2001504479A5
JP2001504479A5 JP1998523345A JP52334598A JP2001504479A5 JP 2001504479 A5 JP2001504479 A5 JP 2001504479A5 JP 1998523345 A JP1998523345 A JP 1998523345A JP 52334598 A JP52334598 A JP 52334598A JP 2001504479 A5 JP2001504479 A5 JP 2001504479A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998523345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001504479A (ja
Filing date
Publication date
Priority claimed from GBGB9623860.5A external-priority patent/GB9623860D0/en
Priority claimed from GBGB9708062.6A external-priority patent/GB9708062D0/en
Application filed filed Critical
Priority claimed from PCT/GB1997/003154 external-priority patent/WO1998022460A1/en
Publication of JP2001504479A publication Critical patent/JP2001504479A/ja
Publication of JP2001504479A5 publication Critical patent/JP2001504479A5/ja
Ceased legal-status Critical Current

Links

JP52334598A 1996-11-15 1997-11-17 二環式アリールカルボキシアミド及びその治療的使用 Ceased JP2001504479A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9623860.5 1996-11-15
GBGB9623860.5A GB9623860D0 (en) 1996-11-15 1996-11-15 Novel compounds
GB9708062.6 1997-04-22
GBGB9708062.6A GB9708062D0 (en) 1997-04-22 1997-04-22 Novel compounds
PCT/GB1997/003154 WO1998022460A1 (en) 1996-11-15 1997-11-17 Bicyclic aryl carboxamides and their therapeutic use

Publications (2)

Publication Number Publication Date
JP2001504479A JP2001504479A (ja) 2001-04-03
JP2001504479A5 true JP2001504479A5 (https=) 2005-07-14

Family

ID=26310411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52334598A Ceased JP2001504479A (ja) 1996-11-15 1997-11-17 二環式アリールカルボキシアミド及びその治療的使用

Country Status (22)

Country Link
US (2) US6353010B1 (https=)
EP (1) EP0944616B1 (https=)
JP (1) JP2001504479A (https=)
KR (1) KR20000053274A (https=)
CN (1) CN1114604C (https=)
AT (1) ATE242234T1 (https=)
AU (1) AU726590B2 (https=)
BR (1) BR9713507A (https=)
CA (1) CA2268037A1 (https=)
CZ (1) CZ158299A3 (https=)
DE (1) DE69722656T2 (https=)
DK (1) DK0944616T3 (https=)
ES (1) ES2200163T3 (https=)
HU (1) HUP0000189A3 (https=)
ID (1) ID21698A (https=)
IL (1) IL129337A0 (https=)
NO (1) NO992337D0 (https=)
NZ (1) NZ335197A (https=)
RU (1) RU2176642C2 (https=)
SK (1) SK283534B6 (https=)
TR (1) TR199901730T2 (https=)
WO (1) WO1998022460A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198734A (ja) * 1998-12-30 2000-07-18 Pfizer Inc 胃運動性減弱および関連疾患の治療のための運動性増強薬
GB0003254D0 (en) * 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
GB0003256D0 (en) * 2000-02-11 2000-04-05 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
KR20040010713A (ko) * 2001-06-15 2004-01-31 야마노우치세이야쿠 가부시키가이샤 페닐피리딘 카보닐 피페라진 유도체
US20040219142A1 (en) * 2002-07-19 2004-11-04 Abbott Laboratories S.A. Treatment of skin and nail disorders using TNFalpha inhibitors
AU2004297235A1 (en) 2003-12-04 2005-06-23 Vertex Pharmaceuticals Incorporated Quinoxalines useful as inhibitors of protein kinases
US20070225308A1 (en) * 2004-03-15 2007-09-27 Kyowa Hakko Kogyo Co.,Ltd. 2-Amino Quinazoline Derivative
NZ560969A (en) * 2005-02-17 2010-08-27 Albany Molecular Res Inc Benzoxazole carboxamides for treating chemotherapy-induced vomiting and irritable bowel syndrome
ES2400287T3 (es) * 2005-03-14 2013-04-08 High Point Pharmaceuticals, Llc Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa
CN102961746B (zh) 2005-05-16 2016-06-15 艾伯维生物技术有限公司 TNFα抑制剂治疗腐蚀性多关节炎的用途
RU2008137612A (ru) * 2006-02-20 2010-03-27 Астеллас Фарма Инк. (Jp) Амидное производное или его соли
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
EP2007426A4 (en) 2006-04-10 2010-06-16 Abbott Biotech Ltd COMPOSITIONS FOR THE TREATMENT OF PSORIASTIC POLYARTHRITIS AND THEIR APPLICATIONS
US7553846B2 (en) * 2006-08-07 2009-06-30 Albany Molecular Research, Inc. 2-alkylbenzoxazole carboxamides as 5-HT3 modulators
JPWO2008026687A1 (ja) * 2006-09-01 2010-01-21 杏林製薬株式会社 ピラゾロピリジンカルボキサミド誘導体及びそれらを含有するホスホジエステラーゼ(pde)阻害剤
KR20090049076A (ko) * 2006-09-07 2009-05-15 바이오겐 아이덱 엠에이 인코포레이티드 인터루킨-1 수용체-결합 키나제 조절물질로서 인다졸 유도체
EP2171451A4 (en) 2007-06-11 2011-12-07 Abbott Biotech Ltd METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
AR067354A1 (es) 2007-06-29 2009-10-07 Sunesis Pharmaceuticals Inc Compuestos utiles como inhibidores de la raf quinasa
AR075633A1 (es) 2009-02-27 2011-04-20 Ambit Biosciences Corp Compuestos moduladores de jak quinasa y sus metodos de uso
WO2012030948A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Quinazoline compounds and methods of use thereof
US9550737B2 (en) * 2012-06-11 2017-01-24 Ucb Biopharma Sprl TNF -α modulating benzimidazoles
EA201590482A1 (ru) * 2012-09-05 2015-07-30 Байер Кропсайенс Аг Применение замещенных 2-амидобензимидазолов, 2-амидобензоксазолов и 2-амидобензотиазолов или их солей в качестве биологически активных веществ против абиотического стресса растений
CN108440333A (zh) * 2018-03-29 2018-08-24 江苏道博化工有限公司 分散染料中间体的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140442A (https=) 1974-04-16 1975-11-11
EP0116938A1 (en) 1983-02-14 1984-08-29 Usv Pharmaceutical Corporation Benzoheterocyclic carbamates
DE3835660A1 (de) * 1988-03-25 1989-10-12 Bayer Ag 7-substituierte 2-carbonamido-benzthiazol-3-oxide
DE4014937A1 (de) 1990-05-10 1991-11-14 Bayer Ag 2,3-disubstituierte chinoxaline als leistungsfoerderer fuer tiere
GB9219634D0 (en) 1992-09-16 1992-10-28 Ici Plc Heterocyclic compounds
GB9219632D0 (en) 1992-09-16 1992-10-28 Ici Plc Heterocyclic compounds
US5559127A (en) 1992-10-14 1996-09-24 Merck & Co., Inc. Fibrinogen receptor antagonists
DE4237617A1 (de) 1992-11-06 1994-05-11 Bayer Ag Verwendung von substituierten Benzimidazolen
GB9301660D0 (en) 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9306578D0 (en) 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
KR100381584B1 (ko) * 1994-07-22 2003-08-21 알타나 파마 아게 디히드로벤조푸란
WO1996004251A1 (en) 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compound
EP0785927B1 (en) * 1994-10-12 2003-08-27 Euroceltique S.A. Novel benzoxazoles
US5665737B1 (en) 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2001500744A5 (https=)
JP2000501599A5 (https=)
JP2000501018A5 (https=)
JP2000500076A5 (https=)
JP2000501324A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2000501338A5 (https=)
JP2000500874A5 (https=)
JP2000502485A5 (https=)
JP2000502425A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000516211A5 (https=)
JP2000501744A5 (https=)
JP2000501229A5 (https=)
JP2000502316A5 (https=)
JP2000500857A5 (https=)
JP2000500184A5 (https=)
JP2000501569A5 (https=)